BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Cai K, Ma J, Chen G, Dang Y, Lu H, Pan S. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis. Pathology - Research and Practice 2019;215:152424. [DOI: 10.1016/j.prp.2019.04.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui X, Li M, He Z, Hu L, Liu J, Yan J, Hua L. MiR-302b-5p enhances the neuroprotective effect of IGF-1 in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease by regulating inducible nitric-oxide synthase. Cell Biochem Funct 2020;38:1025-35. [PMID: 32474958 DOI: 10.1002/cbf.3534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lázár B, Szabadi NT, Anand M, Tóth R, Ecker A, Urbán M, Aponte MTS, Stepanova G, Hegyi Z, Homolya L, Várkonyi EP, Pain B, Gócza E. Effect of miR-302b MicroRNA Inhibition on Chicken Primordial Germ Cell Proliferation and Apoptosis Rate. Genes 2022;13:82. [DOI: 10.3390/genes13010082] [Reference Citation Analysis]
3 Zhang C, Yao Y, Bi L. Hsa_circ_0002162 has a critical role in malignant progression of tongue squamous cell carcinoma through targeting miR-33a-5p. Braz J Med Biol Res 2021;54:e10093. [PMID: 33729388 DOI: 10.1590/1414-431X202010093] [Reference Citation Analysis]
4 Huang HQ, Chen G, Xiong DD, Lai ZF, Liu LM, Fang YY, Shen JH, Gan XY, Liao LF, Dang YW. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. Bioengineered 2021;12:1627-41. [PMID: 33949293 DOI: 10.1080/21655979.2021.1921549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Huang SP, Jiang YF, Yang LJ, Yang J, Liang MT, Zhou HF, Luo J, Yang DP, Mo WJ, Chen G, Shi L, Gan TQ. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma. Cancer Biother Radiopharm 2020. [PMID: 32614608 DOI: 10.1089/cbr.2020.3657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 He RQ, Li JD, Du XF, Dang YW, Yang LJ, Huang ZG, Liu LM, Liao LF, Yang H, Chen G. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. Cancer Cell Int 2021;21:442. [PMID: 34419067 DOI: 10.1186/s12935-021-02130-4] [Reference Citation Analysis]